Four-Point Preprandial Self-Monitoring of Blood Glucose for the Assessment of Glycemic Control and Variability in Patients with Type 2 Diabetes Treated with Insulin and Vildagliptin
The study explored the utility of four-point preprandial glucose self-monitoring to calculate several indices of glycemic control and variability in a study adding the DPP-4 inhibitor vildagliptin to ongoing insulin therapy. This analysis utilized data from a double-blind, randomized, placebo-contro...
Saved in:
| Main Authors: | Andrea Tura, Johan Farngren, Anja Schweizer, James E. Foley, Giovanni Pacini, Bo Ahrén |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2015/484231 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The effects of vildagliptin on glycemic variability in patients with type 2 diabetes on premixed insulin therapy
by: Deyue Kong, et al.
Published: (2025-06-01) -
Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes
by: Bo Ahrén, et al.
Published: (2016-01-01) -
Comparison of the adverse events of preprandial and postprandial lasmiditan intake: A retrospective chart review
by: Yuu Tatsuoka, et al.
Published: (2025-06-01) -
Vildagliptin and its role in the treatment of diabetes mellitus
by: Yury Shavkatovich Khalimov
Published: (2010-09-01) -
Vildagliptin: the first innovative DDP-4 inhibitor
by: Edvin Villkhauer
Published: (2010-09-01)